233 related articles for article (PubMed ID: 19561415)
1. Maximum supportive care, standard conditioning and allogeneic stem cell transplantation for elderly patients with acute myelogenous leukemia.
Petersen FB; Ford CD
Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S7-9. PubMed ID: 19561415
[TBL] [Abstract][Full Text] [Related]
2. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
Valcárcel D; Martino R
Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
[TBL] [Abstract][Full Text] [Related]
3. Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need.
Shimoni A; Nagler A
Best Pract Res Clin Haematol; 2011 Sep; 24(3):369-79. PubMed ID: 21925090
[TBL] [Abstract][Full Text] [Related]
4. Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation Registry.
Faber E; Koza V; Vitek A; Mayer J; Sedlacek P; Zak P; Zapletalova J; Benesova K; Krejcova H; Steinerova K; Maresova I; Cetkovsky P;
Neoplasma; 2007; 54(5):443-6. PubMed ID: 17688375
[TBL] [Abstract][Full Text] [Related]
5. Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
Lekakis L; de Lima M
Expert Rev Anticancer Ther; 2008 May; 8(5):785-98. PubMed ID: 18471050
[TBL] [Abstract][Full Text] [Related]
6. Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML.
Niederwieser D; Lange T; Cross M; Basara N; Al-Ali H
Best Pract Res Clin Haematol; 2006; 19(4):825-38. PubMed ID: 16997186
[TBL] [Abstract][Full Text] [Related]
7. Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges.
Satwani P; Harrison L; Morris E; Del Toro G; Cairo MS
Biol Blood Marrow Transplant; 2005 Jun; 11(6):403-22. PubMed ID: 15931629
[TBL] [Abstract][Full Text] [Related]
8. Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia.
Al-Ali H; Cross M; Lange T; Freund M; Dölken G; Niederwieser D
Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S17-22. PubMed ID: 19561407
[TBL] [Abstract][Full Text] [Related]
9. Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.
Ringdén O; Labopin M; Ehninger G; Niederwieser D; Olsson R; Basara N; Finke J; Schwerdtfeger R; Eder M; Bunjes D; Gorin NC; Mohty M; Rocha V
J Clin Oncol; 2009 Sep; 27(27):4570-7. PubMed ID: 19652066
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias.
Niederwieser D; Gentilini C; Hegenbart U; Lange T; Becker C; Wang SY; Bartsch K; Pönisch W; Raida M; Al-Ali H
Crit Rev Oncol Hematol; 2005 Nov; 56(2):275-81. PubMed ID: 16213741
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease.
Valcárcel D; Martino R; Piñana JL; Sierra J
Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S35-7. PubMed ID: 19561412
[TBL] [Abstract][Full Text] [Related]
12. High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.
Schmid C; Schleuning M; Hentrich M; Markl GE; Gerbitz A; Tischer J; Ledderose G; Oruzio D; Hiddemann W; Kolb HJ
Bone Marrow Transplant; 2008 Apr; 41(8):721-7. PubMed ID: 18176613
[TBL] [Abstract][Full Text] [Related]
13. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.
Craddock CF
Bone Marrow Transplant; 2008 Mar; 41(5):415-23. PubMed ID: 18209726
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome.
de Lima M; Giralt S
Semin Hematol; 2006 Apr; 43(2):107-17. PubMed ID: 16616044
[TBL] [Abstract][Full Text] [Related]
15. Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission.
Martino R; Valcárcel D; Brunet S; Sureda A; Sierra J
Bone Marrow Transplant; 2008 Jan; 41(1):33-8. PubMed ID: 17982504
[TBL] [Abstract][Full Text] [Related]
16. Can reduced-intensity allogeneic transplantation cure older adults with AML?
Storb R
Best Pract Res Clin Haematol; 2007 Mar; 20(1):85-90. PubMed ID: 17336258
[TBL] [Abstract][Full Text] [Related]
17. Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
Alousi A; de Lima M
Clin Adv Hematol Oncol; 2007 Jul; 5(7):560-70. PubMed ID: 17679930
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality.
Meijer E; Cornelissen JJ
Semin Oncol; 2008 Aug; 35(4):449-57. PubMed ID: 18692695
[TBL] [Abstract][Full Text] [Related]
19. Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia.
Cordonnier C; Maury S; Esperou H; Pautas C; Beaune J; Rodet M; Lagrange JL; Rouard H; Beaumont JL; Bassompierre F; Glückman E; Kuentz M; Durand-Zaleski I
Bone Marrow Transplant; 2005 Oct; 36(7):649-54. PubMed ID: 16044135
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia.
Sierra J; Martino R; Sánchez B; Piñana JL; Valcárcel D; Brunet S
Bone Marrow Transplant; 2008 Mar; 41(5):425-37. PubMed ID: 18209727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
